db旗舰,DB真人

Your locations:Home > Newsroom > AVE News

The development of the clinical diagnosis of IgG 4 related disease (IgG4-RD) in China

In the First Catalogue of Rare Diseases, which was jointly developed by the National Health Commission of the PRC and five other departments in 2018, there is a rare disease called IgG4-Related Disease (IgG4-RD).

2016-10-26Globavir announces licensing agreement with Bio-Rad for Globavir’s dengue detection technology
2016-10-25Blood Gas and Electrolyte Analyzer Market Worth USD 636 Million by 2021
2016-09-29Quidel’s Solana Influenza A+B assay wins FDA approval
2016-09-21Global In Vitro Diagnostic Test Market Worth USD 60 Billion
2016-09-19Cancer Biomarker Market to Grow to $7.4B in 2020
2016-09-19Danaher to Acquire Cepheid for USD 4 Billion
2016-09-15Invitation of 76th CMEF (Shenzhen)
2016-08-29WHO accepts altona’s diagnostic test for Zika Virus
2016-08-16FIME 2016 Broadens the Way to Enter Latin American Markets
2016-08-12Invitation of Medica 2016
2016-08-112016 AACC Exhibition Review
2016-07-28FDA Approves First Liquid Biopsy Test For Lung Cancer

About AVE | Newsroom | Products | Service | Contact Us
◎China. Changsha. AVE Science & Technology Co.Ltd. All Rights Reserved